Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

FosL1 Is a Novel Target of Levetiracetam for Suppressing the Microglial Inflammatory Reaction

International Journal of Molecular Sciences(2021)10.3390/ijms222010962Source: DataRank Database

FosL1 Is a Novel Target of Levetiracetam for Suppressing the Microglial Inflammatory Reaction is a research paper published in International Journal of Molecular Sciences (2021). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.02)OA: goldTopics (44)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Ruri Taniguchi,Takeshi Yamazaki ORCID,Mayumi Tsuji ORCID,Kouichi Itoh,Yasuhiro Ishihara ORCID

Live enrichment

PubMed:34681621 PMC:PMC8537483 OpenAlex:https://openalex.org/W3206040570

Japan Society for the Promotion of Science

Grant: 17K08356

Japan Society for the Promotion of Science

Grant: 21K06702

Japan Society for the Promotion of Science

Grant: 17H04714

Japan Society for the Promotion of Science

Grant: 20H04341

FWCI

1.02

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1422-0067/22/20/10962/pdf?version=1634190172

publisherhttps://www.mdpi.com/1422-0067/22/20/10962/pdf?version=1634190172

publisherhttps://www.mdpi.com/1422-0067/22/20/10962/pdf

journalhttps://doi.org/10.3390/ijms222010962

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34681621

Fields of Study

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsDrug Transport and Resistance MechanismsAnimalsDown-RegulationInterleukin-1betaLevetiracetamLipopolysaccharidesMiceMice, Inbred ICRMicrogliaProto-Oncogene Proteins c-fosRNA InterferenceRNA, Small InterferingStatus EpilepticusTranscription Factor AP-1Transcription, GeneticTumor Necrosis Factor-alphaFos-Related Antigen 1

MeSH Terms

LevetiracetamFos-Related Antigen 1AnimalsLipopolysaccharidesMice, Inbred ICRStatus EpilepticusTranscription, GeneticTumor Necrosis Factor-alphaDown-RegulationProto-Oncogene Proteins c-fosMicrogliaTranscription Factor AP-1RNA InterferenceRNA, Small InterferingMiceInterleukin-1beta

Keywords

MicrogliaNeuroinflammationMedicinePharmacologyInflammationImmunologyLevetiracetamFosl1Post-Brain-Insult Epilepsy

Sustainable Development Goals

SDG 0: Good health and well-being